Tuberculosis

Expert Voices

New Global Fund commitments resist pressures on public health backing

Emmanel Macron and Mahamadou Issoufou shake hands in front of flags and a Global Fund sign
Nigerien President Mahamadou Issoufou and French President Emmanuel Macron the Global Fund conference on Oct. 9, 2019. Photo: Olivier Chassignole/AFP via Getty Images

A record $14 billion in commitments made last week to the Global Fund to Fight AIDS, Tuberculosis and Malaria could help the multilateral health partnership save up to 16 million lives while halving mortality rates from the illnesses it targets.

Why it matters: Very few countries are on track to reach the United Nations 2030 Sustainable Development Goal targets for HIV, TB and malaria. The new commitments mark a 15% increase from the previous replenishment three years ago and reflect greater prioritization of preventable disease.

FDA approves new cure for deadly strain of drug-resistant TB

In this image, two hands hold a small rectangular item in front of a child with a head scarf.
A returning patient provides his fingerprint for a biometrics tracking system at an operation ASHA tuberculosis treatment center in 2011, in New Delhi, India. Photo: Andrew Caballero-Reynolds/Getty Images

The Food and Drug Administration on Wednesday approved Pretomanid Tablets, when used alongside 2 other antibiotics, to treat an extremely drug-resistant strain of tuberculosis.

Why it matters: "Tuberculosis has now surpassed AIDS as the world’s leading infectious cause of death," the New York Times reports. The new drug cured 89% of 107 patients with extensively drug-resistant TB after 6 months, when used in combination with antibiotics bedaquiline and linezolid, the FDA said.